ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2026
Modulating the amphiphilic character of porphyrins with pH-activatable cationic centers and fluorocarbon chains to enhance antimicrobial photodynamic activity against Candida albicans.
Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The rise of antifungal-resistant yeast and the increasing prevalence of invasive mycoses, particularly those caused by Candida albicans, pose a significant global public health challenge. This is primarily due to the limited availability of new antifungal drugs and the continuous emergence of multidrug-resistant strains. Photodynamic inactivation (PDI) has emerged as a promising strategy to combat drug-resistant yeast and complex fungal infections. A key factor in improving this therapy is the development of novel and well-designed photosensitizers (PS) capable of selectively targeting and effectively inactivating fungal cells. In this context, we designed and synthesized four novel porphyrin derivatives bearing different numbers of fluorocarbon chains and tertiary alkylamino groups. At physiological pH, the tertiary amines are protonated, forming cationic centers and resulting in compounds with distinct degrees of amphiphilicity. Absorption and fluorescence studies in solution and in cell suspensions showed that the spectroscopic properties of the porphyrin chromophore were preserved across all substitution patterns. All tetrapyrrolic compounds were able to generate reactive oxygen species through both type I and type II photodynamic mechanisms, with similar yields. However, in vitro PDI treatments against C. albicans revealed a significant influence of the substitution patterns on photokilling efficiency. The compound with the highest dipolar moment achieved complete eradication of the treated fungal cell suspension at a concentration of 5.0 µM after 30 min of irradiation. Furthermore, the PDI treatments were extended to biofilm studies, in which this compound also retained superior photoinactivation efficiency against yeast cells embedded in biofilms. These findings indicate that modulating the dipolar character influences photokilling efficacy, providing useful insights for the design of amphiphilic porphyrins with antifungal photodynamic activity.
Indexed as
Identifiers
42165986What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.